Boothbay Fund Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-512,322
| Closed | -$354K | – | 1809 |
|
|
2020
Q4 | $354K | Buy |
512,322
+124,979
| +32% | +$86.4K | 0.01% | 742 |
|
|
2020
Q3 | $872K | Buy |
387,343
+183,985
| +90% | +$414K | 0.05% | 405 |
|
|
2020
Q2 | $728K | Sell |
203,358
-14,827
| -7% | -$53.1K | 0.05% | 395 |
|
|
2020
Q1 | $829K | Buy |
218,185
+89,878
| +70% | +$341K | 0.07% | 295 |
|
|
2019
Q4 | $386K | Buy |
+128,307
| New | +$386K | 0.03% | 466 |
|